RBFOX3 and stroke disorder: While both treatments with 2 × 106 cells/rat and 4 × 106 cells/rat of Neuroncell-EX have significantly higher expression of NeuN compared to stroke control at day 28 (442.50 ± 22.65; p = 0.043 and 469.30 ± 16.99; p = 0.008 versus 338.80 ± 45.90, respectively) as shown in Fig. 5B.